Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation

BACKGROUND: Myocardial ischemia-reperfusion injury (MIRI) is the most common cause of death worldwide. The NOD-, LRR- and pyrin domain-containing protein 3 (NLRP3) inflammasome plays an important role in the inflammatory response to MIRI. Dexmedetomidine (DEX), a specific agonist of α2-adrenergic re...

詳細記述

保存先:
書誌詳細
出版年:BMC Anesthesiol
主要な著者: Huang, Yaru, Sun, Xiaotong, Juan, Zhaodong, Zhang, Rui, Wang, Ruoguo, Meng, Shuqi, Zhou, Jiajia, Li, Yan, Xu, Keyou, Xie, Keliang
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2021
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8022424/
https://ncbi.nlm.nih.gov/pubmed/33823789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12871-021-01334-5
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料